Abstract:Self-assembly of tau into neurotoxic oligomers and fibrils, and cell-to-cell spreading of these pathological tau species are critical processes underlying the pathogenesis of Alzheimer's disease (AD) and other tauopathies. Modulating the self-assembly process and inhibiting formation and spreading of such toxic species are promising strategies for therapy development. A challenge in investigating tau self-assembly in vitro is that unlike most amyloidogenic proteins, tau does not aggregate in the absence of posttranslational modifications or aggregation inducers. The most common induction method is addition of polyanions, such as heparin, yet this artificial system is not an adequate representation of tau self-assembly in vivo, which is driven by aberrant phosphorylation and other PTMs, potentially leading to in-vitro data that do not represent adequately the behavior of tau and its interaction with modulators in vivo. To tackle these challenges, we compared heparin- induce tau and in-vitro phosphorylated tau aggregation and seeding, and their modulation by a “molecular tweezer”. 2N4R tau was either induced to aggregate by heparin or phosphorylated in-vitro either by ERK2 or by whole rat-brain extract. Aggregation was monitored by thioflavin T fluorescence and electron microscopy. Seeding activity was measured in a FRET-based biosensor cell line. Inhibition of these activities by the molecular tweezer, CLR01, was assessed using the same techniques. Heparin-induced tau behaves differently from in-vitro phosphorylated tau. The aggregation rates of the different forms are distinct as is the intracellular localization of the induced aggregates, which resembles brain-derived tau strains. CLR01 inhibits aggregation and seeding of in-vitro-phosphorylated tau dose-dependently, whereas heparin induction interferes with the interaction between CLR01 and tau. In-vitro phosphorylated tau represents a closer proxy of disease-associated hyperphosphorylated tau than heparin-induced tau and a better system for testing assembly modulators. Using heparin-induced tau aggregation is convenient, but may yield misleading results.

Unravelling the Structure and Dynamics of Ac-PHF6-NH2 Tau Segment Oligomers

Unraveling the Structure and Dynamics of Ac-PHF6-NH2 Tau Segment Oligomers

Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling.

Exploring the Aggregation Propensity of PHF6 Peptide Segments of the Tau Protein Using Ion Mobility Mass Spectrometry Techniques

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation

Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass Spectrometry

Structural Insights into the Co-Aggregation of Aβ and Tau Amyloid Core Peptides: Revealing Potential Pathological Heterooligomers by Simulations.

F2-06-01: MAJOR DIFFERENCES BETWEEN THE SELF-ASSEMBLY, SEEDING BEHAVIOR, AND INTERACTION WITH MODULATORS OF HEPARIN-INDUCED VERSUS IN-VITRO PHOSPHORYLATED TAU

Biophysical Studies of Amyloid-Binding Fluorophores to Tau AD Core Fibrils Formed without Cofactors

Uncovering the Effect of Ps202/pt205/ps208 Triple Phosphorylations on the Conformational Features of the Key Fragment G192-T212 of Tau Protein

Molecular Insights into the Differential Effects of Acetylation on the Aggregation of Tau Microtubule-Binding Repeats

Synthesis and conformational properties of phosphopeptides related to the human tau protein.

Deciphering the Effect of Lysine Acetylation on the Misfolding and Aggregation of Human Tau Fragment (171)IPAKTPPAPK(180) Using Molecular Dynamic Simulation and the Markov State Model

Investigation of the Aggregation Process of Amyloid-Β-(16-22) Peptides and the Dissolution of Intermediate Aggregates.

Mechanistic Insights and Future Challenges

Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates

Single‐Molecule Characterization and Super‐Resolution Imaging of Alzheimer's Disease‐Relevant Tau Aggregates in Human Samples

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer's Disease and Other Tauopathies

Direct observation of secondary nucleation in huntingtin amyloid formation by High-Speed Atomic Force Microscopy